Stay updated on Pyrotinib Combo in HR+/HER2- Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Combo in HR+/HER2- Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 was added to the Record History, and the prior revision v3.3.1 was removed.
    Difference
    0.1%
    Check dated 2025-12-01T16:41:56.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The Record History now shows a new revision entry v3.3.1 and removes v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:38:24.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the government funding notice about NIH operational status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T06:22:02.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The latest version adds a Recruitment Status section to the record view, making current enrollment status visible alongside other study details. This enhances visibility of the trial's progress within the page.
    Difference
    0.1%
    Check dated 2025-11-03T00:56:22.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    13%
    Check dated 2025-10-05T09:32:50.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    - Updated recruitment status and study title to reflect a newer version (v3.1.0) and a current date (2025-09-25). - Indicates progression to Active, not recruiting, and a renamed study: 'Pyrotinib Plus Neoadjuvant Chemotherapy in HR+/HER2-, HER4-High Breast Cancer' from the prior title. - Removed older date (2024-11-04) and older revision (v3.0.2) to align with the new revision (v3.1.0).
    Difference
    5%
    Check dated 2025-09-28T03:10:12.000Z thumbnail image

Stay in the know with updates to Pyrotinib Combo in HR+/HER2- Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.